Use of soluble cytokeratin-1-fragments in diagnostics and therapy
US7132246B2 · kind B2 · utility
30Cited by
4References
7Claims
0Family size
Inventors
Key dates
| Filing date | Jun 12, 2002 |
| Grant date | Nov 7, 2006 |
| Priority date | — |
| Expiry date | Jun 12, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/26
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Use of novel soluble cytokeratin 1 fragments from body fluids or body tissues as marker peptides for the diagnosis, prognosis and monitoring of the course of inflammations and infections and/or as a target for the therapeutic influencing of the course of inflammations and/or infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.